Kafrelsheikh University
Kafr ash Shaykh, Kafr el-Sheikh Governorate, 33516, Egypt
NCT Number: NCT05434715
The goals of minimally invasive approaches are better cosmetic results with small neck scar, decreasing postoperative pain, and shortening of hospital stay periods without postoperative complications.
The concept of surgical invasiveness cannot be limited to the length and site of the skin incision; it must be extended to all structures dissected during the procedure. Conventional thyroidectomy without raising subplatysmal flaps has proven to be effective in reducing postoperative pain and seroma
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Kafr ash Shaykh, Kafr el-Sheikh Governorate, 33516, Egypt
Minimal invasive flapless thyroidectomy (MIFT) is a new technique that can be used in replacement of the conventional method of thyroidectomy for the management of selected cases of benign thyroid disorders.
This work aims to evaluate the feasibility, safety, and efficacy of Minimal Invasive Flapless Thyroidectomy (MIFT) in the management of thyroid disease as regards postoperative pain, cosmesis, operative time, and other postoperative complications in comparison to Conventional thyroidectomy technique.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
removal of the thyroid gland
Time frame: 12 months
Degree of scar appearance satisification assessed by the patient and doctor using patient and observer scar assessment scale (POSAS) scale in both groups
Kafrelsheikh University
Other
Evaluation of Minimal Invasive Thyroidectomy; A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01408368
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Krakow, Poland
View Trial DetailsNCT06383481
Endocrine System Diseases, Healthy Lifestyle
Erzurum, palandöken, Turkey (Türkiye)
View Trial DetailsNCT03149354
Blood-Borne Infections, Communicable Diseases
Amiens, Picardie, France
View Trial DetailsNCT04014660
Autoimmune Diseases, Celiac Disease in Children
Malmö, Sweden
View Trial Details